Exeliom Biosciences joins Wilco Incubator

Apr 11, 2024

Exeliom Biosciences announces three phase II clinical trials in immuno-oncology with lead candidate combined with immune checkpoint inhibitors

Explore

#HealthcareInnovation #ClinicalTrial #CDI #Partnership #ExeliomBiosciences #HospicesCivilsdeLyon #MedicalResearch #HealthcareInnovation #ExeliomBiosciences #Biotech #Start-up #Microbiome #Cdiff

Nov 6, 2023

Exeliom Biosciences and Hospices Civils de Lyon announce clinical collaboration in recurrent Clostridioides difficile infection

Explore

#Faecalibacterium #GutHealth #HealthResearch #Microbiome #Biotherapeutics #Biotech

Sep 21, 2023

New review on Faecalibacterium published in FEMS Microbiology Reviews explores its potential for human health

Explore

contact

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.